Cabaletta Bio (CABA) Net Cash Flow (2018 - 2025)

Cabaletta Bio's Net Cash Flow history runs 8 years deep, the most recent figure standing at $22.8 million for Q4 2025.

• In Q4 2025, Net Cash Flow rose 443.86% year-over-year to $22.8 million; the TTM figure through Dec 2025 stood at -$81.0 million (down 176.86% YoY), while the FY2025 annual figure was -$81.0 million, down 176.86% from the prior year.
• Net Cash Flow for Q4 2025 stood at $22.8 million, up from -$85.4 million in the prior quarter.
• The five-year high for Net Cash Flow was $77.7 million in Q4 2023, with the low at -$85.4 million in Q3 2025.
• The 5-year median for Net Cash Flow is $2.8 million (2021), against an average of -$922300.0.
• The sharpest annual moves came in 2021 and 2022: Net Cash Flow soared 649.01% in 2021, then sank 1409.37% in 2022.
• Cabaletta Bio's Net Cash Flow stood at $4.0 million in 2021, then surged by 416.0% to $20.4 million in 2022, then jumped by 280.24% to $77.7 million in 2023, then tumbled by 108.52% to -$6.6 million in 2024, then jumped by 443.86% to $22.8 million in 2025.
• Business Quant data shows CABA's Net Cash Flow at $22.8 million in Q4 2025, -$85.4 million in Q3 2025, and $13.8 million in Q2 2025.